Is there any real reason a far sighted Pharma couldn’t do a deal with PAR prior to 2x2 dose validation.
Cant they just do the deal on the proviso 2x2 gets approved with a walk away clause if 2x2 dose not approved by the FDA etc.
Ann: Type D Response Submitted and Received by the US FDA, page-42
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 24.5¢ | $27.67K | 110.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 138771 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 15889 | 5 |
View Market Depth
| Last trade - 10.44am 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 25.0¢ | 25.0¢ | 25.0¢ | 2906 | ||
| Last updated 11.00am 05/06/2024 ? | |||||
| PAR (ASX) Chart |